Evidence map›Paper›PMID 31905626›Full record

ArticleBiomolecules2019

Oxidized Products of α-Linolenic Acid Negatively Regulate Cellular Survival and Motility of Breast Cancer Cells.

Jorge L Gutierrez-Pajares, Celine Ben Hassen, Camille Oger, Jean-Marie Galano, Thierry Durand, Philippe G Frank

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Therapeutic Potential of Plant Oxylipins.International journal of molecular sciences · 2022
    Review
  3. Metabolomic Profile and Cytotoxic Activity ofPlants (Basel, Switzerland) · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jorge L Gutierrez-PajaresINSERM, Faculté de Médecine, Université de Tours, UMR1069 Tours, France.
Celine Ben HassenINSERM, Faculté de Médecine, Université de Tours, UMR1069 Tours, France.
Camille OgerInstitut des Biomolécules Max Mousseron (IBMM), Université de Montpellier, CNRS, ENSCM Faculté de Pharmacie, UMR5247 Montpellier, France.ORCID 0000-0002-5177-5792
Jean-Marie GalanoInstitut des Biomolécules Max Mousseron (IBMM), Université de Montpellier, CNRS, ENSCM Faculté de Pharmacie, UMR5247 Montpellier, France.
Thierry DurandInstitut des Biomolécules Max Mousseron (IBMM), Université de Montpellier, CNRS, ENSCM Faculté de Pharmacie, UMR5247 Montpellier, France.
Philippe G FrankINSERM, Faculté de Médecine, Université de Tours, UMR1069 Tours, France.ORCID 0000-0003-4857-5279
École Nationale Supérieure de Chimie de Montpellier · FRUniversité de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite recent advances in our understanding of the biological processes leading to the development and progression of cancer, there is still a need for new and effective agents to treat this disease. Phytoprostanes (PhytoPs) and phytofurans (PhytoFs) are non-enzymatically oxidized products of α-linolenic acid that are present in seeds and vegetable oils. They have been shown to possess anti-inflammatory and apoptosis-promoting activities in macrophages and leukemia cells, respectively. In this work, seven PhytoPs (PP1-PP7) and one PhytoFs (PF1) were evaluated for their cytotoxic, chemosensitization, and anti-migratory activities using the MCF-7 and MDA-MB-231 breast cancer cell lines. Among the tested compounds, only three PhytoPs had a significant effect on cell viability compared to the control group:

Indexed as

alpha-Linolenic AcidAntineoplastic AgentsBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationCell SurvivalDrug Screening Assays, AntitumorFemaleFuransHumansMCF-7 CellsOxidation-ReductionProstanoic Acidsalpha-Linolenic AcidAntineoplastic AgentsFuransProstanoic Acidsbreast cancerlipidsphytoprostane

Identifiers

PMID31905626
PMCPMC7023043
OpenAlexW2997885522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.